NYSE:EFORIT
Everforth (EFOR) Lands A $30 Million DHA Contract, Is The Rebound Already Fully Priced?
Everforth (EFOR) stock is in focus after its ECS unit secured a four year, US$30 million prime contract with the Defense Health Agency to support data driven IT modernization and analytics.
See our latest analysis for Everforth.
The recent four year Defense Health Agency contract has arrived during a sharp rebound in Everforth’s share price, with a 30 day share price return of 57.77% and a 90 day share price return of 68.74%. However, the 1 year total shareholder return is still down 38.59%...